Both in Diagnostics
Alpha Teknova vs Myriad Genetics
Over the past year TKNO returned +60.7% and MYGN returned −41.5%; their daily moves had a correlation of 0.19.
TKNO +60.7% MYGN −41.5%Growth of $1, one year, split-adjusted
| Metric | TKNO | MYGN |
|---|---|---|
| Price | $9.08 | $4.23 |
| Market cap | $487.5M | $404.6M |
| Today | −1.30% | −0.24% |
| 1 month | +27.5% | +33.9% |
| 6 months | +238.8% | −3.0% |
| Year to date | +138.9% | −31.2% |
| 1 year | +49.6% | −45.1% |
| Revenue growth (YoY) | +18.5% | −10.5% |
| Gross margin | 40.1% | 66.6% |
| Net margin | −26.0% | −22.7% |
| P/E (TTM) | — | — |
| Price / sales | 11.2× | 0.5× |
| Net cash | $4.2M | -$5.5M |
| Dividend yield | — | — |
| Volatility (60d) | 57.3% | 140.5% |
| Short % of float | 18.7% | 10.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).